Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
The Quadrantid meteor shower peaks tonight, but will the full 'Wolf Moon' outshine the show? - 2Dozens of hidden star streams found in the outskirts of our Milky Way galaxy
- 3Step by step instructions to Buy a Jeep Wrangler on a Senior's Spending plan
- 4A Manual for Pick Great Lawful Discussion Administrations For New businesses In 2024
- 5‘Harry Potter and the Philosopher’s Stone’ trailer is raising eyebrows among Potterheads: ‘Where’s the whimsical color?’
- Transcript: NASA's Jared Isaacman on "Face the Nation with Margaret Brennan," April 5, 2026
- Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- How to watch ‘The Traitors’ U.K. Season 4 from the U.S.
- Haunting Giant Squid Surfaces in Japan and Devours Its Prey (Video)
- Chicago reports first rabies-positive dog in 61 years. What we know.
- NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
- Merz: 80% of Syrians in Germany expected to return within three years
- SpaceX's 1st 'Version 3' Super Heavy Starship booster buckles under pressure during initial tests
- Which One Energizes You the Most These Tech Developments
